Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) für Attention & Focus Difficulties

C

Research suggests omega-3 supplementation may help improve attention and reduce impulsivity. Benefits appear more pronounced in individuals with lower baseline omega-3 levels.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dattention\u002Dfocus'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Fazit

Research suggests omega-3 supplementation may help improve attention and reduce impulsivity. Benefits appear more pronounced in individuals with lower baseline omega-3 levels.

Key Study Findings

Other
An HPLC-MS-Based Method for Determination of the D- and L- 5-Methyltetrahydrofolate Isomer Ratio in Dietary …
Dose: None vs.: None Outcome: separation and quantification of D- and L-5-MTHF diastereomers … Wirkung: None None

Population: None

Review n=321
Current Evidence of Ergogenic and Post-Exercise Recovery Effects of Dietary Supplementation with Cordyceps militaris in …
Dose: None vs.: None Outcome: None Wirkung: None None

Population: healthy individuals aged 16-35 from 5 intervention studies (2017-2024)

Other
Choline in Pediatric Nutrition: Assessing Formula, Fortifiers and Supplements Across Age Groups and Clinical Indications.
Dose: None vs.: None Outcome: Choline content assessment across pediatric products Wirkung: None None

Population: Preterm/term infants and children with CF/kidney disease

Systematic Review
Impact of Vegan and Vegetarian Diets on Neurological Health: A Critical Review.
Dose: None vs.: None Outcome: Neurological health outcomes Wirkung: None None

Population: None

Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None vs.: None Outcome: None Wirkung: None None

Population: None

Meta-Analysis
The Effect of Dietary Supplements on Male Infertility in Terms of Pregnancy, Live Birth, and …
Dose: None vs.: Placebo Outcome: Pregnancy, live birth, sperm parameters Wirkung: None None

Population: Infertile males (50 RCTs, >=12 weeks)

Key Statistics

10

Studien

1800

Teilnehmer

Positive

C

Bewertung

Referenced Papers

Newborn (Clarksville, Md.) 2024 9 Zitierungen
Indian dermatology online … 2021 17 Zitierungen
Journal of pain … 2020 56 Zitierungen
Psychiatrike = Psychiatriki 2020 15 Zitierungen
Clinical pharmacokinetics 2018 128 Zitierungen
Nutricion hospitalaria 2018 32 Zitierungen
Journal of ethnopharmacology 2017 98 Zitierungen
Stem cell investigation 2017 27 Zitierungen
Ageing research reviews 2016 142 Zitierungen
Cannabis and cannabinoid … 2016 77 Zitierungen
Journal of analytical … 2016 49 Zitierungen
Child and adolescent … 2014 42 Zitierungen
Advances in nutrition … 2013 155 Zitierungen
American journal of … 2011 17 Zitierungen
European review for … 2011 9 Zitierungen
The Cochrane database … 2009 299 Zitierungen
The Cochrane database … 2007 375 Zitierungen
Sleep medicine reviews 2007 150 Zitierungen
International journal of … 2005 22 Zitierungen
Journal of clinical … 2004 205 Zitierungen
The Cochrane database … 2003 263 Zitierungen
Journal of Alzheimer's … 2003 161 Zitierungen
Neurochemical research 2003 82 Zitierungen
The British journal … 2001 166 Zitierungen
Pharmacological research 1999 1060 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:
1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:
1,000-1,700 mg/day (optimal dose-response curve)

Obergrenze: 3,000 mg/day combined DHA/EPA (FDA GRAS)

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
None -- Neutral --
None -- Mixed 321
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
1000 mg ferric carboxymaltose -- Positive 58
None -- Mixed --

Beste Einnahmezeit: With meals containing fat for better absorption

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Fishy aftertaste or burping
  • Mild gastrointestinal discomfort
  • Potential increased bleeding time at very high doses
  • May lower blood pressure slightly

Bekannte Wechselwirkungen

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)

Tolerierbare Höchstaufnahmemenge: 3,000 mg/day combined DHA/EPA (FDA GRAS)

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with Attention & Focus Difficulties?
Based on 10 studies with 1,800 participants, there is limited but promising evidence that Omega-3 Fatty Acids (DHA/EPA) may support Attention & Focus Difficulties management. Our evidence grade is C (Some Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Attention & Focus Difficulties?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Attention & Focus Difficulties?
We rate the evidence as Grade C (Some Evidence). This rating is based on 10 peer-reviewed studies with 1,800 total participants. The overall direction of effect is positive.

Related Evidence

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.